Veracyte, Inc. Announces Fourth Quarter and Full-Year 2014 Financial Results, Provides 2015 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Veracyte (VCYT) PT Lowered to $11 at Leerink Partners
March 20, 2015 7:57 AM EDTLeerink Partners analyst Dan Leonard maintained an Outperform rating on Veracyte, Inc (NASDAQ: VCYT) but lowered his price target to $11.00 (from $14.00) following Q4 results.
Leonard commented, "VCYT's revenue for 4Q exceeded the Street and our expectations. While test volume growth is... More
Veracyte (VCYT) Misses Q4 EPS by 3c
March 19, 2015 4:06 PM EDTVeracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $11.83 million.
Veracyte sees FY2015 revenue of $48-53 million, versus the consensus of $59.1 million.
For earnings history and earnings-related data on Veracyte (VCYT) click here.
... More